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Abstract
The ectoparasitic mite, Sarcoptes scabiei that burrows in the epidermis of mammalian skin has a long co-evolution with its
hosts. Phenotypic studies show that the mites have the ability to modulate cytokine secretion and expression of cell
adhesion molecules in cells of the skin and other cells of the innate and adaptive immune systems that may assist the mites
to survive in the skin. The purpose of this study was to identify genes in keratinocytes and fibroblasts in human skin
equivalents (HSEs) that changed expression in response to the burrowing of live scabies mites. Overall, of the more than
25,800 genes measured, 189 genes were up-regulated .2-fold in response to scabies mite burrowing while 152 genes were
down-regulated to the same degree. HSEs differentially expressed large numbers of genes that were related to host
protective responses including those involved in immune response, defense response, cytokine activity, taxis, response to
other organisms, and cell adhesion. Genes for the expression of interleukin-1a (IL-1a) precursor, IL-1b, granulocyte/
macrophage-colony stimulating factor (GM-CSF) precursor, and G-CSF precursor were up-regulated 2.8- to 7.4-fold,
paralleling cytokine secretion profiles. A large number of genes involved in epithelium development and keratinization were
also differentially expressed in response to live scabies mites. Thus, these skin cells are directly responding as expected in an
inflammatory response to products of the mites and the disruption of the skin’s protective barrier caused by burrowing. This
suggests that in vivo the interplay among these skin cells and other cell types, including Langerhans cells, dendritic cells,
lymphocytes and endothelial cells, is responsible for depressing the host’s protective response allowing these mites to
survive in the skin.
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products (molting enzymes and hormones), the physical activity of
the chelicerae, pedipalps and legs as they burrow, and decomposing bodies after they die. However, the live mites have been
observed to produce copious amounts of saliva as they burrow and
this material is likely the source of immune/inflammation
modulating molecules [2]. As products from the mites penetrate
the dermis, they stimulate other cells including fibroblasts,
endothelial cells of the microvasculature and immune effector
cells including LCs, macrophages, mast cells, and lymphocytes [3–
9]. Presumably, LCs and other dendritic cells take up and process
antigens from the mites in the skin and transport them to regional
lymphatic tissue where the adaptive immune response is initiated
via activation of B- and T-lymphocytes.
Live scabies mites induce secretion of the anti-inflammatory
cytokine interleukin-1 receptor antagonist (IL-1ra) from the cells in
human skin equivalents (fibroblasts and keratinocytes) [10]. IL-1ra
inhibits the activity of the proinflammatory cytokine IL-1 by
binding to the IL-1 receptor that is found on many cells including
T-cells, B-cells, natural killer cells, macrophages and neutrophils
[10,11].
Scabies mite extract contains molecules that suppress the
expression of intercellular and vascular cell adhesion molecules
(ICAM-1 and VCAM-1) and E-selectin by cultured normal
human endothelial cells of the skin microvasculature [12]. This

Introduction
The scabies mite, Sarcoptes scabiei is a medically and economically
important ectoparasite of humans and other mammals worldwide.
The mites live in the lower stratum corneum of the skin. All active
life stages of the mite (larvae, protonymph, tritonymph and adults)
are obligate permanent parasites that require host extracellular
fluid (plasma) that seeps into the burrow as nutrition to live [1].
The parasite has had a long co-evolution with its mammalian
hosts and has adapted multiple mechanisms for evading the host
innate and adaptive immune responses. Hosts exhibit delayed
inflammatory and adaptive immune responses to this parasite. In
humans, clinical symptoms (skin inflammation) may not appear for
4 to 8 weeks after initial infestation. It is now clear that this delay is
the result of the mite’s ability to modulate multiple aspects of the
host’s inflammatory and immune responses. Some of these have
been elucidated as discussed below.
Cells of the epidermis such as keratinocytes, dendritic cells and
Langerhans cells (LCs) are the first cells to encounter the mite and
its products. The innate inflammatory and subsequent adaptive
responses of the host skin provide the first line of defense against
the invasion, survival and reproduction of the mite in the skin. The
mites stimulate epidermal keratinocytes and dendritic cells with
molecules in their eggs, feces, excreta, saliva and other secretory
PLOS ONE | www.plosone.org
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host response seems to be a balance between events that both
induce and inhibit the protective response and there seem to be
many targets for modulation by molecules from the mite. The
duration of the infestation and mite burden play a role in shifting
this balance. There is a network of pathways involved in the host
innate and adaptive immune responses to mite antigens. Scabies
antigens and molecules that modulate the host response appear to
influence many points in the networks.
Human skin equivalents (HSEs) consist of an epidermis of
stratum corneum and proliferating keratinocytes grown above a
dermis of fibroblasts in a collagen matrix and have the properties
of human skin. Our previous report [10] was limited in that only
the secretion of selected cytokines by HSEs was monitored. In
order to facilitate identification of other possible innate phenotypic
responses, in the present study we investigated the gene expression
in response to live scabies mites in the same HSEs whose cytokine
secretion was previously reported [10]. This allowed us to
elucidate many more aspects of the inflammatory immune
response to burrowing scabies mites in order to develop a broader
picture of the mites’ immune and inflammation modulating ability.
These data will also identify additional specific sites that may have
potential for developing vaccines for the prevention and treatment
of this disease.

suppression would inhibit or reduce extravasation of lymphocytes,
neutrophils and other cells into the dermis in the vicinity of the
mite and thus hinder the host’s ability to mount a successful
protective response.
Scabies mites may inhibit co-stimulatory interactions between
antigen presenting cells and T-cells. Scabies mite extract induces
human T-regulatory cells to produce IL-10 [13]. IL-10 acts as a
potent anti-inflammatory cytokine by suppressing the secretion of
proinflammatory cytokines and expression of MHC-II molecules
on antigen-presenting cells. Thus, the interaction of the MHC-IIantigen complex and the T-cell receptor necessary for activation
and proliferation of B-cells into antibody secreting plasma cells
would be inhibited/reduced.
Spleen cells from scabies-challenged mice and mice vaccinated
with scabies extract exhibited reduced gene expression for B7-2
(CD86) on B-cells and its receptor, CD28 on T-cells [14]. In
addition, genes for expression of CD40 on B-cells and its receptor,
CD40L on T-cells, were down-regulated. These co-signals
accompany the T-cell receptor MHC-II-antigen complex coupling
that activates a B-cell to become an antibody-producing plasma
cell.
Human skin equivalents and monocultures of normal human
epidermal keratinocytes and dermal fibroblasts increase secretion
of vascular endothelial growth factor (VEGF) in response to live
scabies mites and mite extracts [10,15]. VEGF would increase
vascularity and fluid (plasma) in the mite burrow in the vicinity of
the mouthparts and oral opening of the mite. We believe this fluid
is the main source of water and nutrition for the mite in the
otherwise dry stratum corneum [1]. Evidence for this is that the
mites ingest antibody from the host presumably in this plasma
[16].
Scabies mite products may be able to reduce IL-8 activity in the
vicinity of the scabietic lesion in two ways. IL-8 is a chemokine that
is chemotactic for the extravasation of neutrophils to the site of a
pathogen. Monocultures of human epidermal keratinocytes,
dermal fibroblasts, microvascular endothelial cells of the skin,
and dendritic cells challenged with scabies extract exhibited
reduced levels of IL-8 in the media when compared to
unchallenged controls [12,15,17,18]. Also, there is evidence that
these mites may produce an IL-8 binding protein that may reduce
local IL-8 levels thereby inhibiting chemotaxis of neutrophils
(unpublished).
Scabies gut serine protease inhibitors of the serpin superfamily
have been found to bind to several plasma proteins in the
complement cascades and block the three pathways (classical,
alternative and lectin) of the human complement system [19].
Because scabies mites ingest plasma [16], inactivating host
complement may protect the mite gut from complement-mediated
damage. Complement inhibition may promote the pyoderma
caused by group A streptococci that is often associated with scabies
lesions [20].
As is evident, many aspects of the phenotypic response to these
mites have been elucidated by studies of the responses of cultured
keratinocytes, fibroblasts, endothelial cells, lymphocytes, monocytes and dendritic cells derived from them as well as studies of
gene expression of spleen cells and cytokine profiles of lymph node
cells by flow cytometry. What is clear from these studies is that
mite products modulate many aspects of the host protective
response. Some of these responses have been identified but there
are likely many more.
In contrast to having the ability to down-regulate some aspects
of the host’s protective response, extract and live mites themselves
can up-regulate secretion of proinflammatory cytokines from
keratinocytes, fibroblasts and endothelial cells. Thus, the actual
PLOS ONE | www.plosone.org

Materials and Methods
Scabies Mites and Extract
Live Sarcoptes scabiei variety canis mites were collected by
aspiration onto a 38 mm (400 mesh) stainless steel screen after
they had migrated from skin crusts collected from infested rabbits.
For inoculation onto HSEs, the live mites collected onto the screen
were washed by aspiration of sequential 4 mL volumes of
phosphate-buffered saline with 0.05% Tween-20, endotoxin-free
water (Lonza, Walkersville, MD) and 70% ethanol. For extract
preparation, mites were washed as above, killed by freezing and
later were ground on ice in a Ten Broeck homogenizer in 20
volumes (W/V) endotoxin-free water as previously described [21].
The soluble material was collected following centrifugation and
the supernatant (extract) was sterile filtered into sterile vials.
Protein concentration of the extract was determined by the
Bradford protein assay using bovine serum albumin as the
standard [22].

HSE Challenge
The HSEs used in this study are the same as those whose
cytokine secretion profiles were previously reported [10]. EpiDerm
EFT-400 full-thickness HSEs and medium were purchased from
MatTek (Ashland, MA). Upon arrival, HSEs on their supports
were transferred to new 6-well culture plates containing 3.0 mL of
fresh medium per well and plates were placed in a 37uC incubator
with 5–7% CO2. The next day, HSEs were transferred to new
plates containing 5.0 mL of fresh medium. At the beginning of the
experiment, one set of HSEs (n = 5) were inoculated on their
surfaces with several hundred live scabies mites that had been
washed and surface-sterilized with 70% ethanol. A second set
(n = 5) was inoculated on the surface with 100 mg of soluble scabies
extract protein. A third set (n = 4) remained uninoculated and
served as controls. HSEs were maintained for 48 h at 37uC with
5–7% CO2. At 6, 12, 18, and 24 hours after inoculation, each
HSE on its support was lifted from the well, the medium was
mixed and a 550 mL aliquot was removed from the sample well
and frozen at 280uC for subsequent cytokine secretion measurement as previously reported [10]. At the conclusion of the
challenge, the HSE was lifted from its support and cut into pieces
2
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representation analysis (ORA), performed using GO-Elite v.1
Beta [28]. Maximum raw p-value was set at 0.05. Minimum fold
change was 2.0. GO terms and pathway rankings were pruned by
z-score with a cutoff of 1.96. Minimum number of changed genes
in a term was set at 3. Two-thousand (2000) ORA permutations
were performed, and the primary relational gene database was
Ensembl.

which were submerged in 1.5 mL of RNAlater solution (Ambion
Life Technologies, Grand Island, NY). Samples were stored at
280uC until processed for gene expression analysis.

Gene Expression Analysis
Four HSE replicates for the uninfested control condition and
five HSE replicates for each of the test conditions (live mites, mite
extract) were processed for gene expression analysis. Each
individual HSE was homogenized in 1 mL Trizol (Life Technologies) with the aid of a rotor-stator homogenizer. Following the
manufacturer’s protocol, the aqueous phase from Trizol purification was transferred to EZNA RNA purification columns (Omega
Bio-Tek, Norcross, GA) and purified using the manufacturer’s
protocol. Purified RNA was DNase treated to remove any
contaminating genomic DNA using Turbo DNA-Free (Life
Technologies). RNA was quantified by spectrophotometry and
on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). All samples had RIN numbers .8.0.
For each sample, 50 ng was used as input for the Ambion WT
Expression Kit (Life Technologies). These were hybridized to the
Affymetrix Human Gene 1.0ST arrays (RNA from one HSE
sample per gene chip) according to manufacturer’s protocols.
Briefly, RNA was reverse transcribed using proprietary semirandom primers to generate a first strand cDNA while adding a
T7 promoter and avoiding amplification of rRNA. DNA
polymerase was used with this single-strand cDNA to generate
double stranded cDNA, and then the RNA was degraded by
RNase H. This dscDNA was then in vitro transcribed using T7
RNA polymerase to generate cRNA. After a bead-based
purification (still using the Ambion WT Expression Kit) and
performing the recommended bioanalyzer quality control (Agilent
RNA Nano chip) for cRNA size, the antisense cRNA was
randomly primed to generate ‘‘2nd-cycle’’ cDNA. The RNA was
destroyed by RNase H, and the 2nd cycle cDNA was purified,
again using the Ambion protocol. After another check of yield and
size distribution by bioanalyzer, the 2nd cycle cDNA was labeled,
fragmented, and hybridized to Affymetrix Human Gene 1.0ST
GeneChips using the Affymetrix GeneChip Whole Transcript
Sense Target Labeling Assay protocol (Affymetrix, PN 701880) for
the 169-format GeneChips. All wash and stain reagents were also
obtained directly from Affymetrix and used according to this
manufacturer’s protocols and the recommended fluidics protocols
(FS450_0007 on an Affymetrix Fluidics Station 450). GeneChips
were scanned immediately after fluidics on an Affymetrix
GeneChip 3000 7G scanner. Data from these arrays has been
deposited at the Gene Expression Omnibus (GEO, https://www.
ncbi.nlm.nih.gov/geo) and made publically available. The accession number is GSE48459.
Data analysis was carried out in AltAnalyze version 2.0 [23].
This processes raw CEL files from the scanned arrays using the
RMA algorithm [24–26]. Probesets with DABG (detection above
background) p-values above 0.5 or non-log expression below 1
were removed from the analysis. Gene expression levels were
determined using constitutive probesets (to summarize exon-level
data from the arrays at the gene-level). Gene annotation was
derived from the current version of Ensembl [27] or release 54 in a
handful of cases where the Affymetrix probe set does not correlate
to a current identifier (these were pseudogenes in each case).
Replicates were assigned to groups and pairwise comparisons were
performed for live mites vs. controls and extract vs. controls.
Beginning with the lists of genes significantly differentially
regulated between test and control groups (as determined in
AltAnalyze above), gene functions that appeared significantly
more often were determined by gene ontology (GO) over
PLOS ONE | www.plosone.org

Results
Live Mites on the HSE Surface
In this study, live mites placed on the surface of the HSE
burrowed into the epidermis of the skin equivalent (Fig. 1) and
induced changes in gene expression that were measured at 48 h
post-inoculation. Overall, of the more than 25,800 genes
measured, 189 genes were up-regulated .2-fold (Table 1) in
response to scabies mite burrowing while 152 genes were downregulated to the same degree (Table 2).
We determined that the genes for expression of IL-1a precursor,
IL-1b, GM-CSF precursor, and G-CSF precursor were upregulated 2.8- to 7.4-fold (Table 1). The IL1F9 gene was expressed
8-fold more than in controls and was the second most up-regulated
gene. This gene codes for a protein in the IL-1 cytokine family.
Scabies mites induced a 3.75-times up-regulated expression of the
gene IL1RL1 (IL-1 receptor-like precursor) above its constitutive
expression. Likewise, the genes for the receptors IL1R2 and
IL13RA2 were also up-regulated .2-fold (Table 1).
The gene most up-regulated was KRT37 (also know as Ha 7).
This is a keratin family gene that codes for the type I keratin
protein which heterodimerizes with type II keratin to form hair
and nails. The LCE3C gene encoding for late cornified envelope
protein 3C was up-regulated 4.8-fold above constitutive and

Figure 1. Human skin equivalents (HSEs). Uninoculated controls
(left panels) and HSEs inoculated with mites on the top surface (right
panels). Mites on the surface (S) or burrowed into (B) the HSE are
indicated with arrows.
doi:10.1371/journal.pone.0071143.g001

3

August 2013 | Volume 8 | Issue 8 | e71143

Scabies Mites Modulate Gene Expression in Skin

Table 1. Genes most up-regulated at 48 h by human skin equivalents in response to live scabies mites (all .2-fold vs.
uninoculated controls). Top 50 and selected others of the 189.2x controls.

Rank

Gene Symbol

Definition

Fold6Cont

1

KRT37

Keratin, type I cuticular Ha7

8.46

2

IL1F9

Interleukin-1 family member 9 (IL-1F9)

8.06

3

IL1B

Interleukin-1 beta Precursor (IL-1b)

7.42

4

PRSS22

Brain-specific serine protease 4 Precursor (BSSP-4)

7.39

5

ARG1

Arginase-1 (Type I arginase)

7.21

6

AC011443.6

Iron/zinc purple acid phosphatase-like protein Precursor

6.10

7

CLDN17

Claudin-17

8

AL133512.10

5.08
4.90

9

LCE3C

Late cornified envelope protein 3C

4.82

10

HBEGF

Proheparin-binding EGF-like growth factor Precursor

4.71

11

SLC7A2

Low affinity cationic amino acid transporter 2 (CAT-2)

4.60

4.02

12

AC006032.2

13

FCHSD1

FCH and double SH3 domains protein 1

14

RASGEF1B

Ras-GEF domain-containing family member 1B (GPI c-4)

3.99

15

CSF2

Granulocyte-macrophage colony-stimulating factor Precursor (GM-CSF)

3.99

16

AGPAT9

1-acyl-sn-glycerol-3-phosphate acyltransferase theta

3.96

17

IL1RL1

Interleukin-1 receptor-like 1 Precursor

3.75

18

LCE3A

Late cornified envelope protein 3A (Late envelope protein 13)

3.71

4.03

19

AC026689.6

20

AC004510.1

Urothelial cancer associated 1 (UCA1)

3.63

21

KIAA1239

Leucine-rich repeat and WD repeat-containing protein KIAA1239

3.62

22

RHCG

Ammonium transporter Rh type C

3.54

23

SELE

E-selectin Precursor (Endothelial leukocyte adhesion molecule 1; ELAM-1)

3.54

24

RNF39

RING finger protein 39 (Protein HZFw)

3.53

25

GPR160

Probable G-protein coupled receptor 160

3.46

26

TNIP3

TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3)

3.37

27

RNASE13

Ribonuclease-like protein 13 Precursor

3.24

28

IL1A

Interleukin-1 alpha Precursor (IL-1a)

3.24

29

APOBEC3A

Probable DNA dC-.dU-editing enzyme APOBEC-3A (Phorbolin-1)

3.23

30

PLA2G4D

Cytosolic phospholipase A2 delta (cPLA2-d)

3.20

31

TRPV3

Transient receptor potential cation channel subfamily V member 3 (TrpV3)

3.17

32

PDCD5

Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19)

3.16

33

DHRS9

Dehydrogenase/reductase SDR family member 9 Precursor

3.13

34

ARRDC4

Arrestin domain-containing protein 4

3.11

35

OLAH

S-acyl fatty acid synthase thioesterase, medium chain

3.11

3.67

36

CCL20

C-C motif chemokine 20 Precursor (MIP-3a)[Contains CCL20(1-67)]

3.09

37

KLK9

Kallikrein-9 Precursor (Kallikrein-like protein; (KLK-L3)

3.06

38

HEPHL1

Hephaestin-like protein 1 Precursor

3.06
3.04

39

OASL

59 kDa 29-59-oligoadenylate synthetase-like protein (TRIP-14)

40

U1

U1 spliceosomal RNA

3.01

41

LIPK

Lipase member K Precursor

2.98

42

VNN3

Vascular non-inflammatory molecule 3 Precursor (Vanin-3)

2.97

43

CXCL5

C-X-C motif chemokine 5 Precursor (Epithelial-derived neutrophil-activating protein 78)

2.93

44

LIF

Leukemia inhibitory factor Precursor (LIF)

2.92

45

CHRNB1

Acetylcholine receptor subunit beta Precursor

2.91

46

ZNF208

Zinc finger protein 208

2.89

47

DAZL

Deleted in azoospermia-like (DAZ-like autosomal)

2.87

48

ESM1

Endothelial cell-specific molecule 1 Precursor (ESM-1 secretory protein)

2.85

PLOS ONE | www.plosone.org
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Table 1. Cont.

Rank

Gene Symbol

Definition

Fold6Cont

49

ELF3

ETS-related transcription factor Elf-3 (ESE-1)

2.83

50

IL23A

Interleukin-23 subunit alpha Precursor (IL-23 subunit a)

2.83

52

CSF3

Granulocyte colony-stimulating factor Precursor (G-CSF)

2.80

69

CCL5

C-C motif chemokine 5 Precursor (T-cell-specific protein RANTES)

2.63

79

IL11

Interleukin-11 Precursor (IL-11)

2.46

84

IL13RA2

Interleukin-13 receptor alpha-2 chain Precursor (Interleukin-13-binding protein)

2.43

85

TGFB2

Transforming growth factor beta-2 Precursor (TGF-b2)

2.43

86

CXCL6

C-X-C motif chemokine 6 Precursor (Granulocyte chemotactic protein 2; GCP-2)

2.42

96

IL20

Interleukin-20 Precursor (IL-20)

2.37

124

CCL3

C-C motif chemokine 3 Precursor (Macrophage inflammatory protein 1-alpha; MIP-1a)

2.19

150

LCE2D

Late cornified envelope protein 2D (Late envelope protein 12)

2.12

156

KRT75

Keratin, type II cytoskeletal 75

2.11

160

CXCL2

C-X-C motif chemokine 2 Precursor (Macrophage inflammatory protein 2-alpha; MIP-2a)

2.10

163

KRT38

Keratin, type I cuticular Ha8 (Hair keratin, type I Ha8)

2.09

184

LCE3D

Late cornified envelope protein 3D (Late envelope protein 16)

2.01

186

IL1F6

Interleukin-1 family member 6 (IL-1F6)

2.01

doi:10.1371/journal.pone.0071143.t001

several other LCE genes (LCE3A, LCE2D, LCE3D) were also upregulated by .2-fold.
Conversely, several genes that encode for keratins and are
associated with keratinization were down-regulated (Table 2). The
two genes KRT13 and KRT15, which code for type I
cytokeratins, were down-regulated by 2.20 and 2.37 times below
constitutive expression. Likewise, the gene KRT77 that codes for a
type II keratin, type II cytoskeletal 1b protein, was down-regulated
2.82 times as was KRT1 (2.08-fold down). Several members of the
Ankyrin (ANK2, ANK3, ASB5, ANKRD18A and ANKRD18B)
and Cytochrome P450 (CYP2C18, CYP2J2, CYP3A4, CYP3A5
and CYP3A7) gene families were also down-regulated .2-fold.
Gene ontology (GO) groups provide a useful framework for
describing the cellular component (C), biological process (P), and
molecular function (F) influenced by the expression of a particular
set of genes. The 25 GO groups in which the highest percentage of
genes were differentially expressed by skin equivalents parasitized
with burrowing scabies mites are shown in Table 3. Greater than
87% of the genes in all GO groups were measured and for 23 of
the 25 most highly ranked groups more than 95% were present.
Of the top 15 gene groups expressed, 10 included genes involved
in the regulation of the secretion of cytokines. The GO group of
genes involved in cytokine activity included 23 genes for cytokines
that were changed in HSEs that were challenged by live scabies
mites. Six groups included genes for expression of IL-1a while 14
groups included genes for expression of IL-1b. Of note was that
11% of genes involved in keratinization and 9% of genes in the
taxis GO groups changed expression in response to live scabies
mites.
The 25 GO groups of genes that had the greatest number of
genes that changed expression in response to scabies mites are
listed in Table 4. In response to burrowing scabies mites, HSEs
differentially expressed large numbers of genes that were related to
host protective responses including those involved in immune
response, defense response, cytokine activity, taxis, response to
other organisms, and cell adhesion. A large number of genes
involved in epithelium development and keratinization were also
differentially-expressed in response to live scabies mites.
PLOS ONE | www.plosone.org

Scabies Mite Extract on the HSE Surface
When compared to uninoculated controls, only 15 genes were
differentially expressed by HSEs exposed to soluble scabies mite
extract (Table 5). No genes were significantly (.2-fold) downregulated. Eight of the 15 up-regulated genes were also expressed
more by HSEs exposed to burrowing scabies mites including
KRT37, IL1F9, ARG1, AC011443.6 and LCE3C. Interestingly,
IL1B gene expression was not changed (1.06-fold vs. control).

Discussion
Studies using cultured normal human epidermal keratinocytes
and dermal fibroblasts and dermal endothelial cells of the
microvasculature show a modulation of cytokine secretion and
expression of cell adhesion molecules in response to molecules in
scabies mite extracts [12,15,18,21]. In those studies, the cytokines
and adhesion molecules measured were selected because they were
known to play key roles in immune and inflammatory responses.
However, as a result of those initial studies, it is now apparent that
the possible phenotypic responses to scabies mites and their
products are many. It would be a laborious task to select, identify
and quantify so many of these. In addition, these previous studies
did not determine if mites affect the expression of the receptors for
these cytokines. Also, the use of monocultures of cells in a liquid
media required the use of extracts made from crushed mite bodies
because the mites themselves would not survive in the culture
media of the cells. These limitations led us to use a skin model to
investigate cytokine secretion [10] and gene expression by skin
cells in response to live scabies mites. The use of the HSEs also
allows for the cell-cell interaction between epidermal keratinocytes
and dermal fibroblasts, as is the case in vivo.
Human skin equivalents have physical properties similar to the
epidermis and dermis of normal human skin. They consist of an
epidermis of stratum corneum above keratinocytes layered over a
dermis of fibroblasts. Scabies mites will readily burrow into the
epidermis of these HSEs. Thus, the combined inflammatory and
innate immune responses of the keratinocytes and fibroblasts and
their interactions can be studied in response to burrowing live
5
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Table 2. Genes most down-regulated at 48 h by human skin equivalents in response to live scabies mites (all .2-fold vs.
uninoculated controls). Top 50 and selected others of the 152.26 controls.

Rank

Gene Symbol

Definition

Fold6Cont

1

CYP3A7

Cytochrome P450 3A7

26.03

2

AKR1B10

Aldo-keto reductase family 1 member B10

25.03

3

LAMB4

Laminin subunit beta-4 Precursor (Laminin beta-1-related protein)

25.00

4

DAPL1

Death-associated protein-like 1 (Early epithelial differentiation-associated protein)

24.67

5

AADAC

Arylacetamide deacetylase (AADAC)

24.29

6

HTR3A

5-hydroxytryptamine receptor 3A Precursor (5-HT3R)

24.22

7

C10orf99

Putative uncharacterized protein C10orf99 Precursor

24.01

8

CXCL12

Stromal cell-derived factor 1 Precursor (SDF-1)(C-X-C motif chemokine 12)

23.93

9

ANKRD18A

Ankyrin repeat domain-containing protein 18A

23.76

10

AC108671.5

Putative nmrA-like family domain-containing protein

23.69

11

AL359075.15

Putative uncharacterized protein ENSP00000383760 Fragment

23.51

12

ALDH3A1

Aldehyde dehydrogenase, dimeric NADP-preferring (ALDHIII)

23.29

13

PARP9

Poly [ADP-ribose] polymerase 9 (PARP-9)

23.15

14

40790

Septin-4 (Cell division control-related protein 2)

23.09

15

ANK2

Ankyrin-2 (Brain ankyrin; Ankyrin-B; Non-erythroid ankyrin)

23.08

16

GATM

Glycine amidinotransferase, mitochondrial Precursor (Transamidinase)

23.06

17

PXMP4

Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein)

23.05

18

GBP6

Guanylate-binding protein 6 (GTP-binding protein 6)

23.01

19

AC105921.5-6

20

CA13

21
22

22.88
Carbonic anhydrase 13

22.85

KRT77

Keratin, type II cytoskeletal 1b (Cytokeratin-1B; Keratin-77)

22.82

SEPP1

Selenoprotein P Precursor (SeP)

22.80

23

GNAL

Guanine nucleotide-binding protein G subunit alpha, olfactory type

22.77

24

SLC44A3

Choline transporter-like protein 3

22.77

25

MX1

Interferon-induced GTP-binding protein Mx1

22.68

26

ANK3

Ankyrin-3 (ANK-3; Ankyrin-G)

22.68

27

U4

U4 spliceosomal RNA

22.67

28

APOB

Apolipoprotein B-100 Precursor (Apo B-100)

22.67

29

THEM5

Thioesterase superfamily member 5

22.67

30

PSAT1

Phosphoserine aminotransferase

22.64

31

CYP2C18

Cytochrome P450 2C18

22.64

32

CYP3A4

Cytochrome P450 3A4

22.62

33

IFIT1

Interferon-induced protein with tetratricopeptide repeats 1 (IFIT-1)

22.61

34

AC013251.19-1

35

PSAPL1

Proactivator polypeptide-like 1 Precursor

22.58

36

AK5

Adenylate kinase isoenzyme 5 (AK 5)

22.58

37

OLFML1

Olfactomedin-like protein 1 Precursor

22.56

38

GSTO2

Glutathione S-transferase omega-2 (GSTO-2)

22.56

39

SP110

Sp110 nuclear body protein (Transcriptional coactivator Sp110)

22.54

40

IDH1

Isocitrate dehydrogenase [NADP] cytoplasmic (IDH)

22.53

41

PYDC1

Pyrin domain-containing protein 1 (Pyrin-only protein 1)

22.52

42

BX005195.5

Novel protein similar to contactin associated protein-like 3 (CNTNAP3) Fragment

22.52

43

AL953854.21

Novel protein similar to contactin associated protein-like 3 (CNTNAP3) Fragment

22.52

44

BRCA1

Breast cancer type 1 susceptibility protein (RING finger protein 53)

22.51

45

CNTN1

Contactin-1 Precursor (Neural cell surface protein F3; Glycoprotein gp135)

22.51

46

PCLO

Protein piccolo (Aczonin)

22.50

47

BBOX1

Gamma-butyrobetaine dioxygenase (c-butyrobetaine hydroxylase)

22.49

48

ASB5

Ankyrin repeat and SOCS box protein 5 (ASB-5)

22.48
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Table 2. Cont.

Rank

Gene Symbol

Definition

Fold6Cont

49

ADH1C

Alcohol dehydrogenase 1A (Alcohol dehydrogenase subunit alpha)

22.42

50

Y_RNA

Y RNA

22.42

53

CYP3A5

Cytochrome P450 3A5

22.41

56

KRT15

Keratin, type I cytoskeletal 15 (Cytokeratin-15)

22.37

61

TLR3

Toll-like receptor 3 Precursor (CD283 antigen)

22.33

64

CYP2J2

Cytochrome P450 2J2 (Arachidonic acid epoxygenase)

22.32

86

IL12RB2

Interleukin-12 receptor beta-2 chain Precursor (IL-12 receptor b-2)

22.20

88

KRT13

Keratin, type I cytoskeletal 13 (Cytokeratin-13)

22.20

90

CXCL14

C-X-C motif chemokine 14 Precursor (Chemokine BRAK)

22.19

118

KRT1

Keratin, type II cytoskeletal 1 (Cytokeratin-1)

22.09

129

TNFSF10

Tumor necrosis factor ligand superfamily member 10 (TRAIL)

22.06

143

ANKRD18B

Ankyrin repeat domain-containing protein 18B

22.02

148

IL16

Interleukin-16 Precursor (IL-16)

22.01

doi:10.1371/journal.pone.0071143.t002

scabies mites and their products such as saliva and fecal material.
Our experiments used one set of HSEs to determine both the
cytokine secretion as previously reported in [10] and gene
expression responses of normal human epidermal keratinocytes
and dermal fibroblasts when these tissues were challenged for 48 h
with live mites and their products. By looking at gene expression,
many more possible phenotypic responses could then be considered for phenotypic studies. We recognize that expression of a
gene may not lead to a measurable phenotypic effect. But, given
the long co-evolution of these mites with their mammalian hosts, it
provides a bigger picture of the potential affects these mites have
on modulating the phenotypic response of the host’s structural
cells of the skin and cells involved in inflammatory and immune
responses.
This study found that scabies mites influence expression of
numerous genes. A particularly interesting finding of this study was
the 7.4-fold increase in IL1B gene expression in response to
burrowing scabies mites. These same HSEs exhibited a 4-fold
increase in the secretion of this cytokine onto their surfaces [10].
The IL1B gene is a member of GO groups involved in the
modulation of IL-1ra activity, positive regulation of IL-6 activity
and VEGF production (Table 3). These HSEs also secreted
increased amounts of IL-1ra, IL-6 and VEGF onto their surfaces
in response to burrowing scabies mites [10], perhaps modulated
through the increased IL1B gene expression. IL-1b also stimulates
the expression of the IL1F9 gene and the secretion of this cytokine
by keratinocytes [29] and we observed an 8-fold increase in IL1F9
expression by these HSEs. This cytokine can activate fibroblasts to
produce CCL20 [29] and expression of the CCL20 gene was also
increased 3-fold in parasitized HSEs (Table 1). IL1F9 increases IL6 and IL-8 production by epithelial cells [30] and these HSEs
secreted significantly increased amount of these cytokines in
response to burrowing mites [10]. IL1F9 genes and cytokines are
expressed by keratinocytes during contact hypersensitivity and in
psoriasis patients [31]. It is interesting that burrowing scabies mites
also induce expression of this gene since these skin diseases share
some common clinical features with scabies infestation.
While we found that many GO groups exhibiting a high
percentage of differential gene expression were ones involved in
the secretion of cytokines associated with immune and inflammatory responses, few genes involved with the expression of the
PLOS ONE | www.plosone.org

receptors for these cytokines changed expression. The exceptions
were the up-regulated expression of IL-1R1, IL-1R2 and IL13RA2 genes. Although this would seem to promote inflammation
when IL-1 was secreted by HSEs, we also found that the mites upregulate secretion of IL-1ra that would block the receptor and thus
the pro-inflammatory effects of IL-1 [10].
The genes in the cytokine GO group that changed expression
the most were those that code for IL-1a, IL-1b, IL-11, IL-16, IL20, IL-23, and transforming growth factor-a (TGFa). All of these
are multiple function cytokines and associated with inflammation
in the skin. IL-16 is produced by keratinocytes [32] and is
chemotactic stimulating the migration of CD4+ T-lymphocytes,
monocytes and eosinophils [33,34]. Gene expression for this
cytokine was down-regulated and this could be responsible for the
delay in inflammatory response observed in early scabies. IL-20 is
highly expressed in inflamed tissue such as psoriatic skin [35,36].
During inflammation, IL-20 regulates the proliferation and
differentiation of keratinocytes [35,37,38]. Thus, up-regulation of
IL-20 may contribute to the proliferation of keratinocytes and
development of a thickened epidermis (hyperkeratosis) and the
scaly and crusted skin associated with advanced scabies. IL-23 is
produced in excess in psoriatic skin [39–44]. In vivo, IL-23 is
produced by keratinocytes and dendritic cells and its effect in skin
pathology is mediated by Th17 cytokines [44]. It has been
suggested that blocking IL-17 and IL-23 may suppress chronic
inflammatory diseases [41,44]. Ustekinumab, that blocks IL-23
and IL-12, has been shown to be effective in treating psoriasis [45].
Our finding that the genes for IL-20 and IL-23 are highly
expressed in response to burrowing mites raises the question –
would blocking these cytokines be a possible novel treatment for
reducing the inflammation and itch associated with scabies?
Our earlier studies showed that monocultures of keratinocytes
and/or fibroblasts in response to scabies extracts secreted
cutaneous T cell-attracting chemokine (CTACK, CCL27), thymic
stromal lymphopoietin (TSLP), growth-related oncogene-a
(GROa), transforming growth factor-a (TGFa), IL-1b, IL-3, IL6, IL-8, IL-10, monocyte chemoattractant protein-1 (MCP-1,
CCL2), G-CSF, GM-CSF, macrophage colony-stimulating factor
(M-CSF), VEGF and thymus- and activation-regulated cytokine
(TARC, CCL17) [10]. Mites burrowing into HSEs significantly
up-regulated secretion of CTACK, TSLP, IL-1a, IL-1b, IL-1ra,
7
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F

14

P

P

P

23

24

25

group transfer coenzyme metabolic process

taxis

negative regulation of transport

positive regulation of protein amino acid
phosphorylation

nitric oxide biosynthetic process

positive regulation of lipid metabolic process

platelet activating factor secretion

positive regulation of nuclear division

keratinization

oxygen binding

regulation of cytokine secretion

cytokine activity

positive regulation of JAK-STAT cascade

cellular aldehyde metabolic process

regulation of vasoconstriction

positive regulation of MAPKKK cascade

foam cell differentiation

positive regulation of angiogenesis

aromatase activity

vascular endothelial growth factor production

positive regulation of interleukin-6 production

negative regulation of secretion

positive regulation of tumor necrosis factor
production

juvenile hormone secretion

interleukin-1 receptor antagonist activity

GO Name

35

213

108

78

35

30

41

32

92

37

29

208

24

23

24

39

37

20

25

19

17

41

13

24

9

35

209

99

76

31

29

38

28

91

36

26

197

24

23

23

37

36

20

25

18

17

38

13

24

9

# in GO # Measured

100

98

92

97

89

97

93

88

99

97

90

95

100

100

96

95

97

100

100

95

100

93

100

100

100

% Present

3

18

9

7

3

3

4

3

10

4

3

23

3

3

3

5

5

3

4

3

3

8

3

7

3

# Changed

GO types are characterized according to the gene product’s involvement in biological processes (P) or molecular functions (F).
doi:10.1371/journal.pone.0071143.t003

P

22

P

P

13

21

P

12

P

P

11

20

P

10

P

P

9

P

P

8

19

F

7

18

P

6

P

P

5

17

P

4

F

P

3

P

P

2

16

F

1

15

GO Type

Rank

8.6

8.6

9.1

9.2

9.7

10.3

10.5

10.7

11.0

11.1

11.5

11.7

12.5

13.0

13.0

13.5

13.9

15.0

16.0

16.7

17.6

21.1

23.1

29.2

33.3

% Changed

GBA2, VNN1, VNN3

AC130360.4-3, CCL20, CCL3, CCL5, CXCL12, CXCL14, CXCL2, CXCL5,
CXCL6, DEFB4, FCER1G, FGF2, GPR77, IL16, IL1B, ITGA1, TGFB2, TPM3

ACVR1C, EDN1, FST, HTR2A, IL11, IL1B, INHBA, LIF, SRGN

BMP2, CSF2, FGF2, IL11, IL1B, IL20, LIF

EDN1, IL1B, SLC7A2

ABCG1, APOB, IL1B

ACE2, IL1A, PYDC1, SRGN

EDN1, IL1A, IL1B

AHNAK2, BMP2, FGF2, FST, IL20, LCE2D, LCE3A, LCE3C, LCE3D, SPRR2D

CYP2C18, CYP3A4, CYP3A5, CYP3A7

IL1A, PYDC1, SRGN

BMP2, CCL20, CCL3, CCL5, CSF2, CSF3, CXCL12, CXCL14, CXCL2, CXCL5,
CXCL6, IL11, IL16, IL1A, IL1B, IL1F6, IL1F9, IL20, IL23A, INHBA, LIF, TGFB2,
TNFRSF11B

CSF2, IL20, LIF

AKR1B10, ALDH3A1, IDH1

ACE2, EDN1, HTR2A

IL11, IL1B, LIF, TGFB2, TLR3

ABCG1, APOB, CSF2, INHBA, LIF

FGF2, IL1A, IL1B

CYP2C18, CYP2J2, CYP3A5, CYP3A7

ACE2, IL1A, IL1B

FCER1G, IL1B, TLR3

ACVR1C, EDN1, FST, IL11, IL1B, INHBA, LIF, SRGN

CLEC7A, FCER1G, TLR3

ACVR1C, EDN1, FST, IL11, IL1B, INHBA, LIF

IL1B, IL1F6, IL1F9

Gene symbols of changed genes

Table 3. Gene Ontology (GO) groups in which the highest percentage of genes were differentially expressed by human skin equivalents exposed to live scabies mites.
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Table 4. Gene Ontology (GO) groups in which the greatest number of genes were differentially expressed by human skin
equivalents exposed to live scabies mites.

Rank

GO Type

GO Name

# in GO # Measured % Present

1

P

immune response

884

771

87

# Changed % Changed
47

6.1

2

C

extracellular space

604

576

95

37

6.4

3

P

defense response

734

673

92

34

5.1

4

P

regulation of body fluid levels

958

939

98

31

3.3

5

F

cytokine activity

208

197

95

23

11.7

6

P

epithelium development

458

450

98

21

4.7

7

P

cellular lipid metabolic process

726

707

97

21

3.0

8

P

taxis

213

209

98

18

8.6

9

P

response to other organism

273

263

96

18

6.8

10

P

oxidation reduction

625

599

96

17

2.8

11

P

branching morphogenesis of a tube

303

297

98

16

5.4

12

P

cellular amino acid and derivative metabolic process

424

408

96

16

3.9

13

P

polyphosphate biosynthetic process

602

593

99

16

2.7

14

P

leukocyte activation

372

361

97

15

4.2

15

P

regulation of phosphorylation

420

414

99

15

3.6

16

C

endoplasmic reticulum membrane

550

537

98

15

2.8

17

P

polyphenic determination

584

569

97

15

2.6

18

P

developmental growth involved in morphogenesis

248

242

98

14

5.8

19

P

regulation of cell cycle

365

359

98

13

3.6

20

F

electron carrier activity

287

272

95

12

4.4

21

P

pigment accumulation in tissues

185

178

96

11

6.2

22

C

microsome

195

188

96

11

5.9

23

P

positive regulation of cell proliferation

226

224

99

11

4.9

24

P

cell-cell adhesion

342

331

97

11

3.3

25

P

keratinization

92

91

99

10

11.0

GO types are characterized according to the gene product’s involvement in cellular components (C), biological processes (P), or molecular functions (F).
doi:10.1371/journal.pone.0071143.t004

Table 5. Genes up-regulated at 48 h by human skin equivalents in response to scabies mite extract (all .2-fold vs. uninoculated
controls).

Rank

Gene Symbol

Definition

Fold6Cont

1

ZNF208

Zinc finger protein 208

2.73

2

ARMC4

Armadillo repeat-containing protein 4

2.69

3

LCE3C

Late cornified envelope protein 3C

2.41

4

KRT37

Keratin, type I cuticular Ha7

2.40

5

ARG1

Arginase-1 (Type I arginase)

2.38

6

GSTT2

Glutathione S-transferase theta 2 (GSTT2)

2.25

7

GSTT2B

Glutathione S-transferase theta-2

2.25

8

UPK1A

Uroplakin-1a

2.23

9

TRAPPC2

Trafficking protein particle complex subunit 2

2.21

10

AC011443.6

Iron/zinc purple acid phosphatase-like protein Precursor

2.18

11

U6

U6 spliceosomal RNA

2.10

12

AC116654.4-4

Immunoglobulin Kappa light chain V gene segment

2.06

13

RNF39

RING finger protein 39

2.05

14

FAM70A

Protein FAM70A

2.02

15

IL1F9

Interleukin-1 family member 9 (IL-1F9)

2.00

doi:10.1371/journal.pone.0071143.t005
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IL-6, IL-8, MCP-1, G-CSF, GM-CSF, and M-CSF [10]. We did
not attempt to measure IL-3 and IL-10 secretion by HSEs. Thus,
the HSEs did not significantly up-regulate secretion of GROa,
TGFa, VEGF, and TARC as did extract-challenged keratinocytes
nor did mite-challenged HSEs exhibit a 2-fold change in the
expression of the genes for these four cytokines. Placing soluble
mite extract on the HSE surface did not significantly stimulate
secretion of most of these cytokines [10] nor did it up-regulate
cytokine gene expression for any cytokine other than IL-1b. The
differences in the responses of HSEs and monocultured cells and
between burrowing mites and mite extracts are difficult to
interpret because there can be multiple contributing factors. In
the instance of cultured cells, extract molecules in the culture
media directly stimulate cells. The composition and concentration
of modulating molecules likely varies between what is in an extract
and what is released by a burrowing mite. Also, isolated cells
(keratinocytes and fibroblasts) may respond differently from these
same cells in HSEs that can have cell-cell interactions and
interactions with the matrix. Live burrowing mites that penetrate
the epidermis of HSEs provide a physical stimulus while extracts
placed on the surface of HSEs or in culture media do not. There
are undoubtedly differences in the local concentration of molecules
from the live mite secretions (area around the mouth parts and
anus) and an extract although the later likely contains all the
molecules that the mite secretes. Also, the nature of the
monoculture experiments are such that the cytokines that are
measured have accumulated over time in the culture medium
while gene expression only represents the genes expressed at the
instant the tissue is harvested.
The chemokine genes whose expression was most changed were
CCL3 (MIP-1a), CCL5 (RANTES), CCL20 (MIP-3a), CXCL2
(MIP-2a), CXCL5 (ENA-78), CXCL6 (GCP-2), CXCL12 (SDF1), and CXCL14 (BRAK). All of these genes are members of the
taxis GO group. The secretion of these chemokines was not
determined. This gene expression is consistent with histological
studies of scabietic lesions that show inflammatory cellular
infiltrate that concentrates around the mouth parts and anal
opening of the burrowing mite [46]. This suggests that the effector
molecules responsible for this are associated with salivary
secretions and fecal material and that these induce chemotactic
responses of cells in the vicinity of the mites. However, CXCL12
and CXCL14 were both down-regulated by .2-fold. CXCL12
stimulates the migration of T-lymphocytes, monocytes and
neutrophils [47,48]. CXCL14 (BRAK) is a chemoattractant for
macrophages, immature dendritic cells and natural killer cells [49].

Early down-regulation of these cytokines would be advantageous
for the mite as it is attempting to become established in the host
skin.
Another GO group with many genes affected by burrowing
scabies mites was the keratinization group. This is not surprising
because hyperkeratosis with scaly and crusted skin develops as
scabies infestations progress over time. Ten genes associated with
keratinization were up-regulated. Most of these genes (LCE2D,
LCE3A, LCE3C, LCE3D) are associated with cornification of the
epidermis to become stratum corneum. This is not unexpected
given that the epidermis is damaged by the burrowing mite. The
KRT37 gene was the most up-regulated gene expressed. The
KRT37 protein is a type I keratin found in hair and nails. The
significance of the change in expression of this gene is unclear but
it may be involved in the repair of the epidermis that is damaged
by mite burrowing.

Summary
This study has shown that a large number of genes in skin
keratinocytes and fibroblasts are differentially expressed in
response to live burrowing scabies mites, their products and
physical activity. The HSEs used in this study consisted of only two
cell types (keratinocytes and fibroblasts). The fibroblasts and
keratinocytes in these HSEs seem to be responding to the invading
mites and their products with the expected pro-inflammatory
response. In vivo, many other cell types also respond to the live
scabies mites and their products as well as to the substances
produced by keratinocytes and fibroblasts in response to the mites.
Thus, there is a complex interaction among many cell types in the
skin (including antigen-presenting cells and lymphocytes) in
response to scabies. Most of these interactions remain to be
identified but those already elucidated involve other cell types
including endothelial cells, LCs, dendritic cells and lymphocytes.
Likewise, many of the adaptations that scabies mites have evolved
to modulate and exploit a host remain to be identified. However, it
is clear that these mites are capable of modulating many aspects of
the innate and adaptive protective responses of their host enabling
them to survive and thrive.
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